South Africa has begun rolling out a twice-yearly HIV prevention injection that health officials say could reshape the country’s fight against the epidemic — but U.S. aid cuts and a shortage of available doses are already complicating the rollout.
The shot, given just twice a year, is a sharp departure from the daily oral pills that have long been the standard for HIV prevention. For patients who struggle to maintain a daily pill regimen, the less-frequent schedule could make adherence far easier.
The timing is complicated. U.S. funding cuts have hit global health programs hard, and South Africa’s HIV response has historically depended in part on American aid. With that support reduced, health authorities are trying to stretch limited resources across one of the world’s most severe HIV burdens. The country has more people living with HIV than any other nation.
Supply is the other bottleneck. Doses aren’t arriving in quantities large enough to meet demand, which means the injection won’t reach everyone who could benefit from it — at least not quickly. Who gets prioritized first, and how distribution gets managed, hasn’t been fully detailed publicly.
The June 5 report from NPR didn’t specify how many doses South Africa has secured or when broader access might be achievable.
Originally reported by NPR. Read the original report.
